New treatment options for hemoglobinopathies;Therapeutiques nouvelles des hemoglobinopathies

Presse Medicale

Volumn 26, Issue 20, 1997, Pages 972-976

  De Montalembert, M ^a  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BUTYRIC ACID; ERYTHROPOIETIN; HYDROXYUREA; HEMOGLOBIN F;

HEMOGLOBINOPATHY; HUMAN; REVIEW; SICKLE CELL ANEMIA; THALASSEMIA; BIOSYNTHESIS; BLOOD; BONE MARROW TRANSPLANTATION;

ANEMIA, SICKLE CELL; BONE MARROW TRANSPLANTATION; FETAL HEMOGLOBIN; HEMOGLOBINOPATHIES; HUMANS; THALASSEMIA;

EID: 0030797225     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (32)

1. Chang YC, Moore RD, Serjeant CR, Dover GJ. An analysis of fetal hemoglobin variation in sickle cell disease : the relative contribution of the X-linked factor, β-globin haplotypes, a-globin gene number, gender, and age. Blood 1995 ; 85:1111-17.
2. Kar BC, Sapathy RK, Kuzolik AE, Sirr S, Serjeant BE, Serjeant CR. Sickle cell disease in Orissa state, India. Lancet 1986 ; ii: 1198-201.
3. Platt OS, Thorington BD, Brambilla DJ et al. Pain in sickle cell disease. Rate and risk factors. N Engl J Med 1991 ; 325:11-16.
4. Castro O, Brambila DJ, Thorington B et al. The acute chest syndrome in sickle cell disease: incidence and risk factors. Blood 1994 ; 84:643-9.
5. Bailey K, Morris JS, Thomas P, Serjeant CR. Fetal hemoglobin and early manifestations of homozygous sickle cell disease. Arch Dis Child 1992 ; 67:517-20.
6. Fruchtman SM, Kaplan ME, Peterson P, Mack K, Berk PD, Wasserman LR. Acute leukemia hydroxyurea, and polycythemia vera: an analysis of risk from the Polycythemia Vera Study Group. Blood 1994 ; 84:518 a.
7. Platt O, Dover G, Miller B et al. Hydroxyurea increases Hb F production in sickle cell anemia. Clin Res 1984 ; 32:552 A.
8. Ballas SK, Dover GJ, Charache S. Effect of hydroxyurea on the rheological properties of sickle cell erythrocytes in vivo. Am J Hematol 1989 ; 32:104-11.
9. Bridges K, Barabino G, Brugnara C et al. Hydroxyurea changes SS RBC biochemical/biophysical profiles to that of SC RBCs. Blood 1994 ; 84:413 a.
10. Charache S, Terrin ML, Moore RD et al. Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. N Engl J Med 1995 ; 332:1317-22.
11. Rodgers GP. Stimulation of fetal hemoglobin synthesis using pharmacological agents - update on the NIH experience. Presented at the 21 St annual meeting of the National Sickle Cell Disease Program, Mobile, March 6-9, 1996.
12. Montalembert de M, Belloy M, Bernaudin F et al. Clinical and hematological response of sickle cell children to treatment with hydroxyurea. J Pediatr Hematol Oncol (in press).
13. Claster S, Vichinsky E. Splenic regeneration in two sickle cell patients treated with hydroxyurea. Blood 1994 ; 84:219 a.
14. Rodgers GP, Dover GJ, Uvesaka N, Noguchi C, Schechter AN, Nienhuis AW. Augmentation by erythropoietin of the fetal-hemoglobin response to hydroxyurea in sickle cell disease. N Engl J Med 1993 ; 328:73-80.
15. Goldberg MA, Brugnara C, Dover CJ, Schapira L, Charache S, Bunn HF. Treatment of sickle cell anemia with hydroxyurea and erythropoietin. N Engl J Med 1990 ; 323:366-72.
16. Nagel RL, Vichinsky E, Shah M et al. F reticulocytes response in sickle cell anemia treated with recombinant erythropoietin : a double blind study. Blood 1993 ; 81:9-14.
17. Cozma G, Momen AK, Hazmi MAF, Politis C, Poisson D, Nisli G. Beneficial use of r-HuEpo in sickle cell disease and thalassemia intermedia: interim results. In: Sickle cell disease and thalassemias : new trends in therapy. Beuzard Y, Lubin B, Rosa J eds. Colloque INSERM/John Libbey Eurotext Ltd. Paris 1995 ; 234:207.
18. Perrine SP, Ginder GD, Faller DV et al. A short-term trial of butyrate to stimulate fetal-globin-gene expression in the b-globin disorders. N Engl J Med 1993 ; 328:81-6.
19. Sher GD, Ginder GD, Little J, Yang S, Dover GJ, Olivieri NF. Extended therapy with intravenous arginine butyrate in patients with β-hemoglobinopathies. N Engl J Med 1995 ; 332:1606-10.
20. Dover GJ, Brusilow S, Charache S. Induction of fetal hemoglobin production in subjects with sickle cell anemia by oral sodium phenylbutyrate. Blood 1994 ; 84:339-43.
21. Wood A, Davies SC. Side effects of therapy for induction of foetal hemoglobin (Hb F) in sickle cell disease (SCD). Blood 1995 ; 86:657a.
22. Perrine SP, Dover GH, Daftari P et al. Isobutyramide, an orally bioavailable butyrate analogue, stimulates fetal globin gene expression in vivo and in vitro. Br J Haematol 1994 ; 88:555-61.
23. Liakopoulou E, Blau A, Li Q et al. Stimulation of fetal hemoglobin production by short chain fatty acids. Blood 1995 ; 86:3227-35.
24. Wood A, Davies SC. Induction of haemoglobin F in sickle cell anemia (SS) by sodium valproate. Blood 1995 ; 86:552 a.
25. Salim KA, Salim A. Therapy with sodium valproate is as effective as that with hydroxyurea in preventing painful crises of sickle cell disease. Blood 1995 ; 86:553 a.
26. Stamatoyannopoulos JA, NienhuisAW. Therapeutic approaches to hemoglobin switching: a treatment of hemoglobinopathies. Annu Rev Med 1992 ; 43:497-521.
27. Rodgers GP, Rachmilewitz EA. Novel treatment options in the severe β-globin disorders. Br J Haematol 1995 ; 91:263-8.
28. Bachir D, Galactéros F. Alternatives potentielles à la transfusion érythrocytaire dans les hémoglobinopathies : hydroxyurée (HU), érythropoiétine (EPO), dérivés du butyrate, substituts du sang. Transf Clin Biol 1994 ; 1:35-9.
29. Rachmilewitz EA, Aker M, Perry D, Dover G. Sustained increase in haemoglobin and RBC following long-term administration of recombinant human erythropoietin to patients with homozygous β-thalassaemia. Br J Haematol 1995 ; 90:341-5.
30. Perrine S, Pekatos P, Faller DV et al. Hematologic efficacy and elimination of transfusion requirements in thalassemia major by intermittent low-dose butyrate therapy. Blood 1995 ; 86:1915 a.
31. Lucarelli G, Clift RA, Galimberti M et al. Marrow transplantation for patients with thalassemia: results in class 3 patients. Blood 1996 ; 87:2082-8.
32. Walters MC, Patience M, Sanders JE. Marrow transplantation for sickle cell disease (SCD): results of a multicenter international trial. Blood 1995 ; 86:1654 a.